Lv41
800 积分 2023-04-25 加入
ADAM9: an updated view of its biology and pathology
1小时前
已完结
ADAM9: an updated view of its biology and pathology
1个月前
已完结
Acute vasopressin neutralization improves cardiac function in rats with chronic heart failure
5个月前
已关闭
Tolvaptan, an Orally Active Vasopressin V2‐Receptor Antagonist—Pharmacology and Clinical Trials
5个月前
已完结
OPC-41061, a Highly Potent Human Vasopressin V2-Receptor Antagonist: Pharmacological Profile and Aquaretic Effect by Single and Multiple Oral Dosing in Rats
5个月前
已完结
Glycosphingolipid metabolism and polycystic kidney disease
6个月前
已完结
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
6个月前
已完结
Therapeutic advances in ADPKD: the future awaits
6个月前
已完结
Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier
8个月前
已完结
Systematic comparisons of various markers for mast cell activation in RBL-2H3 cells
9个月前
已完结
皖公网安备34019202002308
